对GOT2缺乏的综合基因型,表型和生物化学特征:一种进展性神经发育障碍,伴有和异常运动
Hannah M German1, Maha S Zaki2, Muhammad A Usmani3
1Section Metabolic Diagnostics, Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
概括
GOT2缺乏症是一种影响线粒体功能的遗传疾病,在儿童中引起严重的发育和脑病变. 新的生物标志物,如低酸盐和高甘-3-酸盐,可能有助于诊断和治疗.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
背景情况:
- 谷氨酸-氧酸转氨酶 (GOT) 或亚斯巴酸氨转移酶存在于细胞质 (GOT1) 和线粒体 (GOT2) 异构体中.
- GOT2对于酸盐-酸盐穿机至关重要,调节细胞内氧化还原恒温.
- 在GOT2中双变异与发育性和性脑病变有关.
研究的目的:
- 为了进一步描述GOT2缺陷的表型谱.
- 研究GOT2变异患者的遗传,临床和生化特征.
- 为了确定GOT2缺乏的诊断和治疗的潜在生物标志物.
主要方法:
- 对11名同卵性GOT2变异的新患者和4名先前报告的患者进行了基因分析.
- 临床评估患者的表型,包括神经发育,神经和形特征.
- 干燥的血斑和患者的纤维细胞细胞的生物化学分析.
主要成果:
- 患者呈现出进展性神经发育迟缓,智力障碍,婴儿,小头症和低血压/性.
- 观察到明显的形特征和神经成像发现 (大脑体积损失,髓化缺陷).
- 生物化学标志物包括低酸盐和高甘-3-酸盐;纤维细胞研究显示,血清/甘氨酸生物合成减少,对酸盐有反应.
结论:
- GOT2 缺乏是发育性脑病变的重要原因.
- 这项研究扩大了GOT2缺乏的已知表型谱.
- 提出了新的生物标志物和潜在的治疗策略 (pyruvate补充剂).
相关概念视频
Inborn Errors of Metabolism
697
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
697
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Potassium Channel Activators
635
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
635
Pleiotropy
43.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Seizures: Classification
1.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K


